We are pleased to announce that the 7th Heidelberg Myeloma Workshop will take place at the Heidelberg University Hospital on the 5th and 6th of April, 2019. This biennial meeting will continue to focus on new developments in multiple myeloma and a panel of internationally renowned experts will discuss the range of current therapeutic approaches. The workshop has been organized by the Multiple Myeloma Section of the Department of Internal Medicine V of Heidelberg University Hospital and the National Center for Tumor Diseases, Heidelberg (NCT). The venue will be the lecture hall in the University Hospital in Heidelberg.
Recent years have seen myeloma patients benefit from more refined diagnostic criteria and a wider range of treatment options. Both the earlier initiation of treatment and a greater appreciation of the importance of targeting sustained deep remissions offer new opportunities to further extend patient survival. Most importantly, there continues to be a growing pipeline of novel agents in Phase III trials and immunotherapeutic approaches have shown great promise in myeloma. Finally, the prospect of cure is no longer remote.
Myeloma is, like any cancer, a range of diseases. We are, however; now able to make use of clinical, chromosomal and molecular markers to accurately identify robust prognostic groups. For the first time, this is allowing us to deliver increasingly targeted and, ultimately, personalized therapy. In parallel, the use of these novel markers in combination with precise imaging techniques is advancing our understanding of myeloma and our ability to treat it.
The 7th Heidelberg Myeloma Workshop will start at 11.45 a.m. on Friday, the 5th of April, 2019. We hope that this program will be of interest to you and look forward to welcoming you to Heidelberg.
Please book early as we are limited to 200 participants.
Prof. Dr. Hartmut Goldschmidt
Prof. Dr. Marc-Steffen Raab